Skip to main content
Top
Published in: International Urology and Nephrology 1/2015

01-01-2015 | Urology - Original Paper

UVA-photoactivated riboflavin effect on isolated vaginal tissues derived from pelvic organ prolapse cases

Authors: Kimberly S. McMillan, Sam Siddighi, Jeffrey S. Hardesty, Joshua J. Yune, Philip J. Chan

Published in: International Urology and Nephrology | Issue 1/2015

Login to get access

Abstract

Purpose

To determine the optimal riboflavin exposure time before UVA irradiation and to study the effects of exogenous collagen on the mechano-tensile stiffness of isolated vaginal tissue strips after riboflavin UVA photoactivation.

Methods

Vaginal tissue strips from pelvic organ prolapse (POP) cases were soaked in 0.1 % riboflavin (0, 10, 20, 30 min), exposed to UVA photoactivation, and tensile stiffness was measured with a tensiometer. Collagen solution was injected (0.2 mL) into each strip, exposed to riboflavin with or without UVA photoactivation, and tensile stiffness was measured (n = 6).

Results

Vaginal tissues treated with riboflavin for 10, 20 or 30 min followed by UVA irradiation displayed 21.2, 32.4 and 33.9 % stronger tensile stiffness, respectively. Exogenous collagen administered before riboflavin UVA photoactivation resulted in 20 % improvement in tensile stiffness. The tensile stiffness of vaginal tissues injected with collagen without the riboflavin UVA treatment was similar to control tissues.

Conclusion

The results demonstrated increased tensile stiffness in isolated POP-derived vaginal tissues after riboflavin UVA photoactivation suggesting improved mechanical properties from collagen cross-linking. Administering exogenous collagen before riboflavin UVA treatment also improved tensile stiffness. More studies are needed to corroborate the present minimally invasive approach for strengthening vaginal tissues.
Literature
1.
go back to reference Smith FJ, Holman CD, Moorin RE, Tsokos N (2010) Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol 116:1096–1100PubMedCrossRef Smith FJ, Holman CD, Moorin RE, Tsokos N (2010) Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol 116:1096–1100PubMedCrossRef
2.
go back to reference Luber KM, Boero S, Choe JY (2001) The demographics of pelvic floor disorders: current observation and future projections. Am J Obstet Gynecol 184:1496–1503PubMedCrossRef Luber KM, Boero S, Choe JY (2001) The demographics of pelvic floor disorders: current observation and future projections. Am J Obstet Gynecol 184:1496–1503PubMedCrossRef
3.
go back to reference Subak LL, Waetjen LE, van den Eeden S et al (2001) Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol 98:646–651PubMedCrossRef Subak LL, Waetjen LE, van den Eeden S et al (2001) Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol 98:646–651PubMedCrossRef
4.
go back to reference Machin SE, Mukhopadhyay S (2011) Pelvic organ prolapse: review of the aetiology, presentation, diagnosis and management. Menopause Int 17:132–136PubMed Machin SE, Mukhopadhyay S (2011) Pelvic organ prolapse: review of the aetiology, presentation, diagnosis and management. Menopause Int 17:132–136PubMed
5.
go back to reference Lince SL, van Kempen LC, Vierhout ME et al (2012) A systematic review of clinical studies on hereditary factors in pelvic organ prolapse. Int Urogynecol J 23:1327–1336PubMedCentralPubMedCrossRef Lince SL, van Kempen LC, Vierhout ME et al (2012) A systematic review of clinical studies on hereditary factors in pelvic organ prolapse. Int Urogynecol J 23:1327–1336PubMedCentralPubMedCrossRef
6.
go back to reference Lang JH, Zhu L, Sun ZJ et al (2003) Estrogen levels and estrogen receptors in patients with stress urinary incontinence and pelvic organ prolapse. Int J Gynaecol Obstet 80:35–39PubMedCrossRef Lang JH, Zhu L, Sun ZJ et al (2003) Estrogen levels and estrogen receptors in patients with stress urinary incontinence and pelvic organ prolapse. Int J Gynaecol Obstet 80:35–39PubMedCrossRef
7.
go back to reference Wu JM, Visco AG, Grass EA et al (2012) Matrix metalloproteinase-9 genetic polymorphisms and the risk for advanced pelvic organ prolapse. Obstet Gynecol 120:587–593PubMedCentralPubMedCrossRef Wu JM, Visco AG, Grass EA et al (2012) Matrix metalloproteinase-9 genetic polymorphisms and the risk for advanced pelvic organ prolapse. Obstet Gynecol 120:587–593PubMedCentralPubMedCrossRef
8.
go back to reference Dviri M, Leron E, Dreiher J, Mazor M, Shaco-Levy R (2011) Increased matrix metalloproteinases-1,-9 in the uterosacral ligaments and vaginal tissue from women with pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol 156:113–117PubMedCrossRef Dviri M, Leron E, Dreiher J, Mazor M, Shaco-Levy R (2011) Increased matrix metalloproteinases-1,-9 in the uterosacral ligaments and vaginal tissue from women with pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol 156:113–117PubMedCrossRef
10.
go back to reference Meijerink AM, van Rijssel RH, van der Linden PJ (2013) Tissue composition of the vaginal wall in women with pelvic organ prolapse. Gynecol Obstet Invest 75:21–27PubMedCrossRef Meijerink AM, van Rijssel RH, van der Linden PJ (2013) Tissue composition of the vaginal wall in women with pelvic organ prolapse. Gynecol Obstet Invest 75:21–27PubMedCrossRef
11.
go back to reference Wollensak G, Spoerl E, Seiler T (2003) Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135:620–627PubMedCrossRef Wollensak G, Spoerl E, Seiler T (2003) Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135:620–627PubMedCrossRef
12.
go back to reference Mazzotta C, Balestrazzi A, Baiocchi S et al (2007) Stromal haze after combined riboflavin-UVA corneal collagen crosslinking in keratoconus: in vivo confocal microscopic evaluation. Clin Experiment Ophthalmol 35:580–582PubMedCrossRef Mazzotta C, Balestrazzi A, Baiocchi S et al (2007) Stromal haze after combined riboflavin-UVA corneal collagen crosslinking in keratoconus: in vivo confocal microscopic evaluation. Clin Experiment Ophthalmol 35:580–582PubMedCrossRef
13.
go back to reference Gkika M, Labiris G, Kozobolis V (2011) Corneal collagen cross-linking using riboflavin and ultraviolet-A irradiation: a review of clinical and experimental studies. Int Opthalmol 4:309–319CrossRef Gkika M, Labiris G, Kozobolis V (2011) Corneal collagen cross-linking using riboflavin and ultraviolet-A irradiation: a review of clinical and experimental studies. Int Opthalmol 4:309–319CrossRef
14.
go back to reference Ibusuki S, Halbesma GJ, Randolph MA, Redmond RW, Kochevar IE, Gill TJ (2007) Photochemically cross-linked collagen gels as three-dimensional scaffolds for tissue engineering. Tissue Eng 13:1995–2001PubMedCrossRef Ibusuki S, Halbesma GJ, Randolph MA, Redmond RW, Kochevar IE, Gill TJ (2007) Photochemically cross-linked collagen gels as three-dimensional scaffolds for tissue engineering. Tissue Eng 13:1995–2001PubMedCrossRef
15.
go back to reference Ibusuki S, Papadopoulos A, Ranka MP et al (2009) Engineering cartilage in a photochemically crosslinked collagen gel. J Knee Surg 22:72–81PubMedCrossRef Ibusuki S, Papadopoulos A, Ranka MP et al (2009) Engineering cartilage in a photochemically crosslinked collagen gel. J Knee Surg 22:72–81PubMedCrossRef
16.
go back to reference Krishna CM, Uppuluri S, Riesz P, Zigler JS Jr, Balasubramanian D (1991) A study of the photodynamic efficiencies of some eye lens constituents. Photochem Photobiol 54:51–58PubMedCrossRef Krishna CM, Uppuluri S, Riesz P, Zigler JS Jr, Balasubramanian D (1991) A study of the photodynamic efficiencies of some eye lens constituents. Photochem Photobiol 54:51–58PubMedCrossRef
17.
go back to reference Zhang Y, Conrad AH, Conrad GW (2011) Effects of ultraviolet-A and riboflavin on the interaction of collagen and proteoglycans during corneal cross-linking. J Biol Chem 286:13011–13022PubMedCentralPubMedCrossRef Zhang Y, Conrad AH, Conrad GW (2011) Effects of ultraviolet-A and riboflavin on the interaction of collagen and proteoglycans during corneal cross-linking. J Biol Chem 286:13011–13022PubMedCentralPubMedCrossRef
18.
go back to reference Schultz KJ, Siddighi S, Hardesty JS, Waggonner DB, Yune JJ, Chan PJ (2014) UVA-photoactivated riboflavin treatment of vaginal cells derived from pelvic organ prolapse cases. Gynecol Obstet Invest 77:100–103PubMedCrossRef Schultz KJ, Siddighi S, Hardesty JS, Waggonner DB, Yune JJ, Chan PJ (2014) UVA-photoactivated riboflavin treatment of vaginal cells derived from pelvic organ prolapse cases. Gynecol Obstet Invest 77:100–103PubMedCrossRef
19.
go back to reference Liapis A, Bakas P, Pafiti A et al (2001) Changes of collagen type III in female patients with genuine stress incontinence and pelvic floor prolapse. Eur J Obstet Gynecol Reprod Biol 97:76–79PubMedCrossRef Liapis A, Bakas P, Pafiti A et al (2001) Changes of collagen type III in female patients with genuine stress incontinence and pelvic floor prolapse. Eur J Obstet Gynecol Reprod Biol 97:76–79PubMedCrossRef
20.
go back to reference Emge LA, Durfee RB (1966) Pelvic organ prolapse: four thousand years of treatment. Clin Obstet Gynecol 9:997–1032PubMedCrossRef Emge LA, Durfee RB (1966) Pelvic organ prolapse: four thousand years of treatment. Clin Obstet Gynecol 9:997–1032PubMedCrossRef
21.
go back to reference Lensen EJ, Withagen MI, Kluivers KB, Milani AL, Vierhout ME (2013) Surgical treatment of pelvic organ prolapse: a historical review with emphasis on the anterior compartment. Int Urogynecol J 24:1593–1602PubMedCrossRef Lensen EJ, Withagen MI, Kluivers KB, Milani AL, Vierhout ME (2013) Surgical treatment of pelvic organ prolapse: a historical review with emphasis on the anterior compartment. Int Urogynecol J 24:1593–1602PubMedCrossRef
22.
go back to reference Word RA, Pathi S, Schaffer JI (2009) Pathophysiology of pelvic organ prolapse. Obstet Gynecol Clin North Am 36:521–539PubMedCrossRef Word RA, Pathi S, Schaffer JI (2009) Pathophysiology of pelvic organ prolapse. Obstet Gynecol Clin North Am 36:521–539PubMedCrossRef
23.
go back to reference Zhou L, Lee JH, Wen Y, Constantinou C, Yoshinobu M, Omata S, Chen B (2012) Biomechanical properties and associated collagen composition in vaginal tissue of women with pelvic organ prolapse. J Urol 188:875–880PubMedCrossRef Zhou L, Lee JH, Wen Y, Constantinou C, Yoshinobu M, Omata S, Chen B (2012) Biomechanical properties and associated collagen composition in vaginal tissue of women with pelvic organ prolapse. J Urol 188:875–880PubMedCrossRef
24.
go back to reference Moalli PA, Shand SH, Zyczynski HM et al (2005) Remodeling of vaginal connective tissue in patients with prolapse. Obstet Gynecol 106:953–963PubMedCrossRef Moalli PA, Shand SH, Zyczynski HM et al (2005) Remodeling of vaginal connective tissue in patients with prolapse. Obstet Gynecol 106:953–963PubMedCrossRef
25.
go back to reference Ferrari MM, Rossi G, Biondi ML, Viganò P, Dell’utri C, Meschia M (2012) Type I collagen and matrix metalloproteinase 1, 3 and 9 gene polymorphisms in the predisposition to pelvic organ prolapse. Arch Gynecol Obstet 285:1581–1586PubMedCrossRef Ferrari MM, Rossi G, Biondi ML, Viganò P, Dell’utri C, Meschia M (2012) Type I collagen and matrix metalloproteinase 1, 3 and 9 gene polymorphisms in the predisposition to pelvic organ prolapse. Arch Gynecol Obstet 285:1581–1586PubMedCrossRef
26.
go back to reference Shynlova O, Bortolini MA, Alarab M (2013) Genes responsible for vaginal extracellular matrix metabolism are modulated by women’s reproductive cycle and menopause. Int Braz J Urol 39:257–267PubMed Shynlova O, Bortolini MA, Alarab M (2013) Genes responsible for vaginal extracellular matrix metabolism are modulated by women’s reproductive cycle and menopause. Int Braz J Urol 39:257–267PubMed
27.
go back to reference Zong W, Meyn LA, Moalli PA (2009) The amount and activity of active matrix metalloproteinase 13 is suppressed by estradiol and progesterone in human pelvic floor fibroblasts. Biol Reprod 80:367–374PubMedCentralPubMedCrossRef Zong W, Meyn LA, Moalli PA (2009) The amount and activity of active matrix metalloproteinase 13 is suppressed by estradiol and progesterone in human pelvic floor fibroblasts. Biol Reprod 80:367–374PubMedCentralPubMedCrossRef
28.
go back to reference Ruiz-Zapata AM, Kerkhof MH, Zandieh-Doulabi B, Brölmann HA, Smit TH, Helder MN (2013) Fibroblasts from women with pelvic organ prolapse show differential mechanoresponses depending on surface substrates. Int Urogynecol J 24:1567–1575PubMedCentralPubMedCrossRef Ruiz-Zapata AM, Kerkhof MH, Zandieh-Doulabi B, Brölmann HA, Smit TH, Helder MN (2013) Fibroblasts from women with pelvic organ prolapse show differential mechanoresponses depending on surface substrates. Int Urogynecol J 24:1567–1575PubMedCentralPubMedCrossRef
29.
go back to reference Jackson SR, Avery NC, Tarlton JF, Eckford SD, Abrams P, Bailey AJ (1996) Changes in metabolism of collagen in genitourinary prolapse. Lancet 347:1658–1661PubMedCrossRef Jackson SR, Avery NC, Tarlton JF, Eckford SD, Abrams P, Bailey AJ (1996) Changes in metabolism of collagen in genitourinary prolapse. Lancet 347:1658–1661PubMedCrossRef
30.
go back to reference Narayanan AS, Page RC, Swanson J (1989) Collagen synthesis by human fibroblasts. Regulation by transforming growth factor-beta in the presence of other inflammatory mediators. Biochem J 260:463–469PubMedCentralPubMed Narayanan AS, Page RC, Swanson J (1989) Collagen synthesis by human fibroblasts. Regulation by transforming growth factor-beta in the presence of other inflammatory mediators. Biochem J 260:463–469PubMedCentralPubMed
31.
go back to reference Esquenazi S, He J, Li N et al (2010) Immunofluorescence of rabbit corneas after collagen cross-linking treatment with riboflavin and ultraviolet A. Cornea 29:412–417PubMedCentralPubMedCrossRef Esquenazi S, He J, Li N et al (2010) Immunofluorescence of rabbit corneas after collagen cross-linking treatment with riboflavin and ultraviolet A. Cornea 29:412–417PubMedCentralPubMedCrossRef
Metadata
Title
UVA-photoactivated riboflavin effect on isolated vaginal tissues derived from pelvic organ prolapse cases
Authors
Kimberly S. McMillan
Sam Siddighi
Jeffrey S. Hardesty
Joshua J. Yune
Philip J. Chan
Publication date
01-01-2015
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2015
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-014-0836-5

Other articles of this Issue 1/2015

International Urology and Nephrology 1/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.